Inventor · disambiguated record
Julian Egger
Also filed as: EGGER JULIAN
4 granted patents·4 pending applications·0 citations·filing 2018–2024
55Inventor score
Files withBAYER AG8
Top patents by PatentIndex Score
8 records- 0177US12202805B2Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compoundBAYER AG·Filed 2023·Granted Jan 21, 2025·0 cites·27 claims
- 0272US12138256B2Treatment of cardiopulmonary disordersBAYER AG·Filed 2023·Granted Nov 12, 2024·0 cites·30 claims
- 0371US2025263381A1Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compoundBAYER AG·Filed 2024·Application pending·0 cites
- 0469US2025090519A1Treatment of cardiopulmonary disordersBAYER AG·Filed 2024·Application pending·0 cites
- 0556US2025281480A1Pharmaceutical dry powder inhalation formulationBAYER AG·Filed 2022·Application pending·0 cites
- 0651US2023183181A1Process of preparing butyl-(5s)-5-({2-[4-(butoxycarbonyl)phenyl]ethyl}[2-(2-{[3-chloro-4'-(trifluoromethyl)[biphenyl]-4-yl]methoxy}phenyl)ethyl]amino)-5,6,7,8-tetrahydroquinoline-2-carboxylateBAYER AG·Filed 2021·Application pending·0 cites
- 0744US11542245B2Preparative processBAYER AG·Filed 2019·Granted Jan 3, 2023·0 cites·17 claims
- 0836US11053518B2Method for the preparation of chiral alpha haloalkanoic acidsBAYER AG·Filed 2018·Granted Jul 6, 2021·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Julian Egger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →